189 related articles for article (PubMed ID: 20817429)
21. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
Selivanova OA; Gouveris H; Victor A; Amedee RG; Mann W
Otol Neurotol; 2005 Sep; 26(5):890-5. PubMed ID: 16151334
[TBL] [Abstract][Full Text] [Related]
22. Intratympanic injection of dexamethasone as an alternative treatment of steroid-dependent sensorineural hearing loss associated with aortitis syndrome.
Murofushi T; Nakahara H; Sakata A; Matsuzaki M
Auris Nasus Larynx; 2007 Jun; 34(2):225-8. PubMed ID: 17049780
[TBL] [Abstract][Full Text] [Related]
23. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.
Gouveris H; Schuler-Schmidt W; Mewes T; Mann W
Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933
[TBL] [Abstract][Full Text] [Related]
24. Intratympanic injection with dexamethasone for sudden sensorineural hearing loss.
Tsai YJ; Liang JG; Wu WB; Ding YF; Chiang RP; Wu SM
J Laryngol Otol; 2011 Feb; 125(2):133-7. PubMed ID: 21054907
[TBL] [Abstract][Full Text] [Related]
25. Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss.
Kakehata S; Sasaki A; Futai K; Kitani R; Shinkawa H
Audiol Neurootol; 2011; 16(3):191-7. PubMed ID: 20962524
[TBL] [Abstract][Full Text] [Related]
26. Sudden sensorineural hearing loss: results of intratympanic steroids as salvage treatment.
Dispenza F; De Stefano A; Costantino C; Marchese D; Riggio F
Am J Otolaryngol; 2013; 34(4):296-300. PubMed ID: 23357592
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy.
Suzuki H; Hashida K; Nguyen KH; Hohchi N; Katoh A; Koizumi H; Ohbuchi T
Laryngoscope; 2012 May; 122(5):1154-7. PubMed ID: 22447636
[TBL] [Abstract][Full Text] [Related]
28. [The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss].
Yang J; Huang L; Shi J; Li Y; Wu H; Kong W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jul; 24(13):594-7. PubMed ID: 20842947
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness.
Gundogan O; Pinar E; Imre A; Ozturkcan S; Cokmez O; Yigiter AC
Otolaryngol Head Neck Surg; 2013 Nov; 149(5):753-8. PubMed ID: 23959817
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment.
Ho HG; Lin HC; Shu MT; Yang CC; Tsai HT
Laryngoscope; 2004 Jul; 114(7):1184-9. PubMed ID: 15235345
[TBL] [Abstract][Full Text] [Related]
31. Comparison of therapeutic results in sudden sensorineural hearing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases.
Liu SC; Kang BH; Lee JC; Lin YS; Huang KL; Liu DW; Su WF; Kao CH; Chu YH; Chen HC; Wang CH
Clin Otolaryngol; 2011 Apr; 36(2):121-8. PubMed ID: 21414179
[TBL] [Abstract][Full Text] [Related]
32. Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss.
Baysal E; Tunç O; Baglam T; Durucu C; Oz A; Karatas ZA; Polat M; Celenk F; Mumbuc S; Kanlikama M
J Craniofac Surg; 2013 Mar; 24(2):432-4. PubMed ID: 23524709
[TBL] [Abstract][Full Text] [Related]
33. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss.
Slattery WH; Fisher LM; Iqbal Z; Friedman RA; Liu N
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):251-9. PubMed ID: 16087024
[TBL] [Abstract][Full Text] [Related]
34. Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss.
Hatano M; Uramoto N; Okabe Y; Furukawa M; Ito M
Acta Otolaryngol; 2008 Feb; 128(2):116-21. PubMed ID: 17851951
[TBL] [Abstract][Full Text] [Related]
35. Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss.
Li L; Ren J; Yin T; Liu W
Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):861-7. PubMed ID: 22669272
[TBL] [Abstract][Full Text] [Related]
36. Dose Effect of Intratympanic Dexamethasone for Idiopathic Sudden Sensorineural Hearing Loss: 24 mg/mL Is Superior to 10 mg/mL.
Alexander TH; Harris JP; Nguyen QT; Vorasubin N
Otol Neurotol; 2015 Sep; 36(8):1321-7. PubMed ID: 26196209
[TBL] [Abstract][Full Text] [Related]
37. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss.
Battista RA
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):902-5. PubMed ID: 15944562
[TBL] [Abstract][Full Text] [Related]
38. Round window membrane vibration may increase the effect of intratympanic dexamethasone injection.
Park SH; Moon IS
Laryngoscope; 2014 Jun; 124(6):1444-51. PubMed ID: 24155116
[TBL] [Abstract][Full Text] [Related]
39. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
Murphy D; Daniel SJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss.
Satar B; Hidir Y; Yetiser S
J Laryngol Otol; 2006 Aug; 120(8):665-9. PubMed ID: 16762093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
